Evidence map›Paper›PMID 21266840›Full record

ArticleVirulence

Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials.

Thormika Keo, Jennifer Collins, Pratima Kunwar, Martin J Blaser, Nicole M Iovine

Open access · goldAbstract read
In one paragraph

Article in Virulence. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
12.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Therapeutic and protective approaches to combatFrontiers in pharmacology · 2025
    Review
  4. Review
  5. Microorganisms · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. A Systematic Review ofMicroorganisms · 2021
    Review
  16. Article
  17. Virulence Traits of InpatientMicroorganisms · 2020
    Article
  18. RevisitingFrontiers in cellular and infection microbiology · 2020
    Review
  19. Review
  20. Human Immunity AgainstImmune network · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Thormika KeoDepartment of Microbiology, New York University School of Medicine, NY, USA.
Jennifer Collins
Pratima Kunwar
Martin J Blaser
Nicole M Iovine
New York University · USUniversity of Florida · USUniversity of Washington · US

Funding

CELL-SURFACE PROTEINS IN CAMPYLOBACTER FETUS VIRULENCER01AI024145 · NIAID · VANDERBILT UNIVERSITY · PI BLASER, MARTIN J · 1988 to 2004
$1.4M
NIAID NIH HHS R01 AI024145NIAID NIH HHS R01 AI24145
6 · The paper itself

Abstract

The innate immune system plays a critical role in host defense against mucosal bacteria. Campylobacter jejuni is a major cause of human gastroenteritis that usually resolves spontaneously within several days, suggesting that innate mechanisms are important to control the infection. However, the specific means by which this occurs is not well understood. While diarrheal isolates of C. jejuni usually are susceptible to human serum, we found that a systemic strain of C. jejuni, isolated from the cerebrospinal fluid of an infant with meningitis, is relatively more resistant to human serum, the Bactericidal/Permeability-Increasing Protein (BPI), an endogenous cationic antimicrobial protein, and the cationic peptide antibiotic polymyxin B. To test the hypothesis that the surface properties of this strain contributed to its ability to withstand these innate host defenses, we constructed isogenic mutants in capsule (kpsM) and lipooligosaccharide (waaF) and complemented these mutants by insertion of the complementation construct in trans into hipO, a chromosomal locus. We found that capsule expression was essential for serum resistance, whereas lipooligosaccharide played no substantial role. In contrast, the lipooligosaccharide mutant showed increased sensitivity to polymyxin B, α-defensins, cathelicidins, and BPI. These findings suggest that the polysaccharides of C. jejuni strains contribute differently to resistance against host innate immunity; whereby capsule is more important for resisting human complement and lipooligosaccharide is more important for protection against killing mediated by cationic antimicrobial peptides and proteins.

Indexed as

Blood Bactericidal ActivityDrug Resistance, BacterialAnti-Bacterial AgentsAntimicrobial Cationic PeptidesBacterial CapsulesCampylobacter InfectionsCampylobacter jejuniHumansLipopolysaccharidesSerumAnti-Bacterial AgentsAntimicrobial Cationic Peptideslipid-linked oligosaccharidesLipopolysaccharides

Identifiers

PMID21266840
PMCPMC3073237
OpenAlexW2025733027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.